OR WAIT null SECS
October 09, 2023
Purchase allows company to provide a fully integrated small-to-medium scale sterile injectable service offering for the biopharma industry.
October 05, 2023
Boehringer Ingelheim’s unbranded adalimumab-adbm biosimilar will be available at an 81% discount to adalimumab (Humira).
October 04, 2023
The newly established business under Advent International and Warburg Pincus will be named Simtra BioPharma Solutions.
Exec joins the organization with decades of biopharma experience.
October 03, 2023
Statistics shows it up 1.5%, representing first annual growth since February 2022
September 28, 2023
Pharmaceutical product distributor continues goal of delivering safe and affordable medication to patients.
CTDMO is reportedly the first to provide this aforementioned service, which spans through commercialization.
September 26, 2023
Shares expected to be offered on Six Swiss Exchange.
Abrysvo reportedly reduces risk of condition in baby by 57% in the first six months after birth.
September 25, 2023
CDMO purchases branded sachet-packaging machine for commercial manufacturing.